Applied Biosciences Corp.
APPB
$0.00
$0.000.00%
| 12/31/2019 | 09/30/2019 | 06/30/2019 | 03/31/2019 | 12/31/2018 | |
|---|---|---|---|---|---|
| Revenue | 860.00K | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 860.00K | -- | -- | -- | -- |
| Cost of Revenue | 331.50K | -- | -- | -- | -- |
| Gross Profit | 528.30K | -- | -- | -- | -- |
| SG&A Expenses | 3.05M | -- | -- | -- | -- |
| Depreciation & Amortization | 160.00K | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.54M | -- | -- | -- | -- |
| Operating Income | -2.68M | -- | -- | -- | -- |
| Income Before Tax | -3.06M | -- | -- | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.06 | -- | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 274.30K | -- | -- | -- | -- |
| Net Income | -2.79M | -- | -- | -- | -- |
| EBIT | -2.68M | -- | -- | -- | -- |
| EBITDA | -2.52M | -- | -- | -- | -- |
| EPS Basic | -0.20 | -- | -- | -- | -- |
| Normalized Basic EPS | -0.11 | -- | -- | -- | -- |
| EPS Diluted | -0.20 | -- | -- | -- | -- |
| Normalized Diluted EPS | -0.11 | -- | -- | -- | -- |
| Average Basic Shares Outstanding | 55.13M | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | 55.13M | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
